RISA Labs
RISA Labs builds BOSS, an AI operating system for oncology that automates prior authorization, benefits verification, and revenue cycle workflows via multi-agent LLMs, digital twins, and Evolvable DAG orchestration. It sells annual enterprise SaaS subscriptions to US cancer centers, health systems, specialty pharmacies, and infusion networks.
- Company typePrivate
- Founded2025
- HeadquartersPalo Alto, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What RISA Labs does
RISA Labs, Inc. is a US-based, venture-backed private company building an AI Operating System for oncology administrative workflows, marketed under the brand name BOSS (Business Operating System as a Service). The platform deploys multi-agent LLM systems, specialized digital twins (Medical Necessity Twin, Care Navigator Twin, Clinical History Twin), and a proprietary Evolvable DAG orchestration layer to automate prior authorization, benefits verification, claims status tracking, denial management, and clinical decision support across cancer centers, specialty pharmacies, infusion networks, and health systems.
The product surface is delivered through three named components: BOSS as the core operating system platform, BOSS Console as the command and control dashboard for institutional configuration and audit traceability, and OneRISA as the unified prior authorization module covering both medical and pharmacy authorizations across 1,200+ medications in oncology and adjacent specialties. RISA integrates bi-directionally with EMRs (including a named Flatiron Health partnership), payer portals, clearinghouses, and e-fax channels. Reported technical benchmarks include 95.6% accuracy on medical necessity checklist judgment and 86.2% accuracy on item-level judgments with evidence.
RISA generates revenue through annual enterprise SaaS subscriptions sold via direct field sales to large oncology practices, cancer centers, health systems, specialty pharmacies, and infusion networks in the United States. Pricing is quote-based and not publicly disclosed. The company has raised $14.6M total ($3.5M seed in April 2025 led by Binny Bansal; $11.1M Series A in January 2026 co-led by Cencora Ventures and Optum Ventures), is headquartered in Palo Alto with engineering operations in Bangalore, and operates a distributed workforce across 79 US and India locations. Named customers include New York Cancer & Blood Specialists, OneOncology, Astera Cancer Care, Tennessee Oncology, Mary Bird Perkins Cancer Center, and others.
RISA Labs firmographics
Firmographics- Name
- RISA Labs
- Legal name
- RISA Labs, Inc.
- Website
- https://risalabs.ai
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- RISA Labs builds BOSS, an AI operating system for oncology that automates prior authorization, benefits verification, and revenue cycle workflows via multi-agent LLMs, digital twins, and Evolvable DAG orchestration. It sells annual enterprise SaaS subscriptions to US cancer centers, health systems, specialty pharmacies, and infusion networks.
- Ownership category
- akta.pro rank
RISA Labs industry classification
Industry- Product category
- Oncology Workflow Automation Software
- NAICS
- Software Publishers (513210), Computer Systems Design Services (541512)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- iBPMS (Intelligent BPM Suites) & Process Automation Suites (HDAEAHAG)
Keywords
Where RISA Labs is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
RISA Labs business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- AI OS Platform Subscription: SaaS-based AI operating system for oncology workflows delivered as a subscription model to cancer centers, health systems, specialty pharmacies, and infusion networks. Pricing based on institutional scale with configurable workflows through BOSS Console.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription for oncology practices |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
RISA Labs product offering
Product offeringCore offering
RISA Labs sells an AI operating system (BOSS — Business Operating System as a Service) that automates oncology administrative workflows for cancer centers, health systems, specialty pharmacies, and infusion networks. The platform decomposes prior authorization, benefits verification, claims status tracking, and denial management into micro-tasks delegated to multi-agent AI systems (LLMs, digital twins, reinforcement learners) orchestrated by an Evolvable DAG engine. Delivered as enterprise SaaS with quote-based annual subscriptions and deployed directly into partner institutions' EMR, payer, and benefits environments.
Product overview
RISA Labs provides an AI operating system for oncology workflows, consisting of BOSS (Business Operating System as a Service) as the core platform, BOSS Console as the command center interface, and OneRISA as the unified prior authorization platform covering both medical and pharmacy authorizations. The system unifies patient access, benefits verification, and prior authorization across cancer centers, specialty pharmacies, and infusion networks. Powered by Evolvable DAGs technology, the platform deploys multi-agent AI systems including LLMs, digital twins, and reinforcement learners to automate oncology administrative workflows end-to-end.
Differentiator
Problem solved
Functional benefit
Brands
- BOSS Console: RISA's command control panel for mission-critical institutions, allowing each institution to tailor workflows, routing, document conventions, and practice-specific rules. The platform unifies access, benefits, and prior authorization across cancer centers, specialty pharmacies, and infusion networks.
Products and services
- BOSS (Business Operating System as a Service) AI operating system for oncology that orchestrates patient access, benefits verification, and prior authorization workflows across cancer centers, specialty pharmacies, and infusion networks. Decomposes complex workflows into micro-tasks delegated to AI agents including LLMs, digital twins, and reinforcement learners, sold as an enterprise SaaS subscription to oncology institutions.
- BOSS Console Command and control dashboard for mission-critical oncology institutions. Enables teams to manage and configure workflows, routing, document conventions, and practice-specific rules. Provides full traceability of AI decisions with audit-ready documentation and real-time visibility into system actions.
- OneRISA Unified prior authorization platform covering both medical authorizations and pharmacy authorizations for oncology and adjacent specialties. Integrates clinical context, payer guidelines, and operational execution for oncology treatment access and reimbursement workflows. Supports 1,200+ medications across specialties including oncology, urology, hematology, cardiology, gastroenterology, pulmonology, dermatology, gynecology, rheumatology, and neurology.
Quantifiable outcome
- 97.8% first-pass approval rate vs 65% industry average
- +7 more outcomes
Companies that use RISA Labs
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles3 records
RISA Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability8 records
Feature10 records
RISA Labs partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Flatiron HealthcoreEMR integration partner. RISA's BOSS system integrates with Flatiron Health's EMR to enable real-time data synchronization and workflow automation.
Scale indicators14 records
Recent moves6 records
Expansion highlights6 records
RISA Labs competitors and assessment
Company assessmentDirect peers
- Cohere Health: AI-powered prior authorization and utilization management platform serving health plans and providers. Most directly comparable to RISA in clinical prior authorization workflows, with similar payer-aligned GTM and AI-driven medical necessity assessment.
- Anterior: Clinical AI platform focused on prior authorization automation for health plans and providers. Directly comparable technology stack and target customer base, with similar emphasis on AI-driven medical necessity decisioning.
- Infinx: Prior authorization and revenue cycle management solutions for healthcare providers, with strong oncology specialty pharmacy presence. Direct competitor in the same PA workflow automation category.
- AKASA: AI platform automating healthcare revenue cycle operations including prior authorization, claims, and denials. Comparable AI-native architecture targeting similar provider customers with workflow automation.
- Notable: Intelligent automation platform for healthcare workflows including patient access and administrative processes. Comparable AI-driven approach to automating healthcare administrative tasks at provider organizations.
Broad incumbents
- Olive AI: Healthcare AI automation platform addressing revenue cycle, prior authorization, and administrative workflows across multiple provider verticals. Comparable broad healthcare AI automation positioning though less oncology-specialized.
- Waystar: Public healthcare revenue cycle technology platform serving thousands of hospitals and providers with eligibility, prior authorization, and claims management. Broader incumbent competing across RCM categories where RISA plays.
- Experian Health: Healthcare division offering eligibility verification, prior authorization, and claims management to providers. Large incumbent with established payer data network competing in overlapping workflow categories.
- Availity: Healthcare information network connecting providers and payers for eligibility, prior authorization, and claims processing. Established incumbent with deep payer relationships competing in the same provider-payer workflow space.
Emerging players
- Humata Health: AI platform automating prior authorization for specialty drugs and complex therapies. Early-stage with comparable AI-native approach to specialty pharmacy prior authorization — overlapping target segment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
RISA Labs social profiles
Digital presenceRISA Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
RISA Labs leadership team
Management profileNumber of profiles
Profiles3 records
RISA Labs funding detail
Funding detailFunding overview
Funding rounds2 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RISA Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RISA Labs
What does RISA Labs do?
RISA Labs sells an AI operating system (BOSS — Business Operating System as a Service) that automates oncology administrative workflows for cancer centers, health systems, specialty pharmacies, and infusion networks. The platform decomposes prior authorization, benefits verification, claims status tracking, and denial management into micro-tasks delegated to multi-agent AI systems (LLMs, digital twins, reinforcement learners) orchestrated by an Evolvable DAG engine. Delivered as enterprise SaaS with quote-based annual subscriptions and deployed directly into partner institutions' EMR, payer, and benefits environments.
Is RISA Labs a public or private company?
RISA Labs is a private company. It is classified as venture growth investor backed and is currently operating.
When was RISA Labs founded?
RISA Labs was founded in 2025. It employs 11 to 50 people.
Where is RISA Labs based?
RISA Labs is headquartered in Palo Alto, United States, in the North America region.
How does RISA Labs make money?
One revenue line is on record: AI OS Platform Subscription.
Who are RISA Labs's main competitors?
Direct peers on record are Cohere Health, Anterior, Infinx, AKASA and Notable. Broad incumbents are Olive AI, Waystar, Experian Health and Availity. Humata Health is listed as an emerging player.
Does RISA Labs have an API?
No public API is recorded for RISA Labs.
What industry is RISA Labs in?
RISA Labs's product category is Oncology Workflow Automation Software. Its primary akta.pro industry code is HDAEAHAG, iBPMS (Intelligent BPM Suites) & Process Automation Suites. Its NAICS code is 513210 and its SIC code is 7372.